94 related articles for article (PubMed ID: 29773022)
1. Tumor Necrosis Factor: Function, Release and Clearance.
Bemelmans MHA; van Tits LJH; Buurman WA
Crit Rev Immunol; 2017; 37(2-6):249-259. PubMed ID: 29773022
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor: function, release and clearance.
Bemelmans MH; van Tits LJ; Buurman WA
Crit Rev Immunol; 1996; 16(1):1-11. PubMed ID: 8809470
[TBL] [Abstract][Full Text] [Related]
3. Influence of nephrectomy on tumor necrosis factor clearance in a murine model.
Bemelmans MH; Gouma DJ; Buurman WA
J Immunol; 1993 Mar; 150(5):2007-17. PubMed ID: 8436831
[TBL] [Abstract][Full Text] [Related]
4. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
Vey E; Burger D; Dayer JM
Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
[TBL] [Abstract][Full Text] [Related]
6. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
7. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
[TBL] [Abstract][Full Text] [Related]
8. Detection of membrane-bound tumor necrosis factor (TNF): an analysis of TNF-specific reagents.
Gerspach J; Götz A; Zimmermann G; Kolle C; Böttinger H; Grell M
Microsc Res Tech; 2000 Aug; 50(3):243-50. PubMed ID: 10891890
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
Pan W; Csernus B; Kastin AJ
J Mol Neurosci; 2003; 21(2):173-84. PubMed ID: 14593216
[TBL] [Abstract][Full Text] [Related]
10. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Amrani Y; Panettieri RA; Frossard N; Bronner C
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
Terlizzese M; Simoni P; Antonetti F
J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
Kondo S; Sauder DN
Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor and anti-tumor necrosis factor therapies.
Keystone EC; Ware CF
J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75--and TNF receptor p55-deficient mice.
Broide DH; Stachnick G; Castaneda D; Nayar J; Sriramarao P
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):304-11. PubMed ID: 11245629
[TBL] [Abstract][Full Text] [Related]
16. Effect of nutrition on tumor necrosis factor receptors in weight-gaining and -losing rats.
Raina N; Lamarre J; Liew CC; Lofti AH; Jeejeebhoy KN
Am J Physiol; 1999 Sep; 277(3):E464-73. PubMed ID: 10484358
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor and its p55 and p75 receptors are not required for axonal lesion-induced microgliosis in mouse fascia dentata.
Fenger C; Drojdahl N; Wirenfeldt M; Sylvest L; Jorgensen OS; Meldgaard M; Lambertsen KL; Finsen B
Glia; 2006 Nov; 54(6):591-605. PubMed ID: 16927297
[TBL] [Abstract][Full Text] [Related]
18. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome.
Koski H; Janin A; Humphreys-Beher MG; Sorsa T; Malmström M; Konttinen YT
Clin Exp Rheumatol; 2001; 19(2):131-7. PubMed ID: 11326474
[TBL] [Abstract][Full Text] [Related]
20. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
Butler DM; Feldmann M; Di Padova F; Brennan FM
Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
